TRPC6 and focal segmental glomerulosclerosis: Gain-of-function mutations of TRPC6 lead to focal and segmental glomerulosclerosis (FSGS), a common and increasing cause of the end-stage renal disease (Winn et al., 2005; Riehle et al., 2016).